Shionogi is proud to sponsor the SUPERBUGS: THE FIGHT FOR OUR LIVES exhibit at the Science Museum, London. For more information, click here
Shionogi Limited, the London-based European subsidiary of Shionogi & Co., Ltd announce that the European Medicines Agency (EMA) accepted its Marketing Authorisation Application (MAA) submission for naldemedine.. read more..
Shionogi & Co., Ltd. (hereafter “Shionogi”) announced that Symproic® (generic name: naldemedine tosilate) was approved today by the Ministry of Health, Labor and Welfare for the treatment of opioid-induced constipation (OIC). Read more ...
If you are interested in joining Shionogi, visit the join us page!